Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Compound. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112279779B details a mild copper-catalyzed asymmetric oxime etherification. Discover high-ee pharmaceutical intermediates and cost-effective manufacturing solutions.
Patent CN113930415A details a novel enzymatic route for antifungal intermediates, offering high stereoselectivity and simplified purification for scalable manufacturing.
Patent CN107400036A reveals rhodium-catalyzed synthesis enabling high enantioselectivity. Delivers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Discover the Rh-catalyzed asymmetric hydrogenation patent CN116444412A for chiral trifluoromethyl nitrogen heterocycles. Achieve high ee values and cost reduction in pharmaceutical intermediate manufacturing with scalable solutions.
Discover a novel palladium-catalyzed method for synthesizing chiral indole-2,3-fused eight-membered rings. Efficient, scalable route for high-purity pharmaceutical intermediates.
Patent CN115477667B reveals mild organocatalytic route for chiral silanes. Offers supply chain stability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110655456B details Co-catalyzed hydrogenation of E/Z mixed olefins. Offers high ee and conversion for pharmaceutical intermediates.
Patent CN113429323A details a metal-free organocatalytic route for high-ee sulfonyl styrenes, offering cost-effective scalability for pharmaceutical intermediates.
Patent CN115850336B reveals metal-free synthesis for high-purity axial chiral compounds. Enables cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN116947643A reveals Rh-catalyzed hydrogenation for high-purity axial chiral compounds. Offers supply chain reliability and cost reduction in pharma intermediate manufacturing.
Novel asymmetric catalytic synthesis of chiral nitrogen-bridged rings. High stereoselectivity, scalable process for pharmaceutical intermediates and supply chain reliability.
Patent CN118126082A introduces amino acid-derived catalyst for high-purity chiral phosphorus intermediates, offering metal-free synthesis and scalable production for global pharmaceutical supply chains.
Patent CN105330608B details high-ee urazole synthesis. Discover cost-effective, scalable chiral ligand manufacturing for pharmaceutical applications.
Novel synthesis of chiral optical pure alkynylamide substituted α,β-diamino acid derivatives via Rh-catalyzed three-component reaction for potent anticancer applications.
Patent CN113292598A discloses a Rh(III)-catalyzed enantioselective synthesis of axial chiral biaryl compounds with P-stereocenters, offering significant supply chain advantages.
Novel metal-free asymmetric deuteration method using D2O. High enantioselectivity for pharma intermediates. Cost-effective supply chain solution.
Patent CN102993065B details a novel Lewis acid-catalyzed route for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Novel heterogeneous copper catalyst enables high yield chiral synthesis for pharmaceutical intermediates supply chain optimization and significant cost reduction capabilities for global buyers.
Patent CN111763157B reveals a novel one-step asymmetric synthesis for chiral amino compounds, enabling cost reduction in pharmaceutical manufacturing and safer scale-up.
Patent CN106242935A reveals a green water-oil two-phase synthesis for triaryl chiral compounds. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.